Using both observational and genetic mediation analyses, we show that the impact of the IL-6 pathway on risk of type 2 diabetes due to obesity is modest (3–5%), which challenges a prevailing hypothesis that IL-6 has an important role in the link between obesity and diabetes risk. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.